This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
At Montana Psychiatry, our providers and staff are dedicated to serving the mental health needs of children and adults in our region. We aim to provide compassionate, thoughtful, and comprehensive care by using an integrated approach that focuses on biological, psychological, and social factors that are unique to each patient. We strive for excellence in our delivery of care and offer cutting edge treatments such as Deep TMS therapy and interventions to restore hope and quality of life for patients and families.
Please fill all the marked fields